BeautyHealth Promotes Aesthetics Vet Brad Hauser To COO

The Beauty Health Company has promoted Brad Hauser to chief operating officer, a new position within the company.

Hauser will assume end-to-end operating leadership, overseeing the company’s full product lifecycle, from ideation and innovation to go-to-market. He will continue to lead the organization, including technology, R&D, quality assurance, and regulatory affairs, and will take on new responsibilities overseeing operations and marketing. He will remain a member of the company’s executive committee, reporting to President and CEO Andrew Stanleick.

Hauser joined BeautyHealth in January 2023 as chief product officer. Prior, he led product development, R&D and business integration for top medical device and pharmaceutical companies, including Allergan Aesthetics, Zeltiq Aesthetics, Cutera and Solta Medical. He also served as CEO of Soliton, Inc. during its development of the novel cellulite and tattoo removal medical device Resonic.

“Brad is an industry veteran, and since joining BeautyHealth he has demonstrated outstanding leadership, most recently in preparing the business for the international launch of Syndeo, our next generation connected device, which is off to an encouraging start,” said Stanleick. “Positioning Brad to have full line of sight, from concept to market, will enable the Company to move thoughtfully and with speed, especially on our most important initiatives. Brad brings seasoned executive experience and, as COO, will further strengthen our global leadership capabilities as we take advantage of the sizable growth runway ahead.”